Non-V600E <i>BRAF</i> mutations and treatment for hairy cell leukemia
Evgeny Arons(National Institutes of Health), R. J. Kreitman(National Institutes of Health), Constance M. Yuan(National Cancer Institute), Mark Raffeld(National Cancer Institute), Liqiang Xi(Center for Cancer Research), Kerry A. Rogers(The Ohio State University), Seema A. Bhat(The Ohio State University), Chin‐Hsien Tai(National Institutes of Health), Hao‐Wei Wang(Fu Jen Catholic University), Daniel Jones(University of Namur), M N Gould(National Institutes of Health), Isaac Shpilman(National Institutes of Health), Michael R. Grever(The Ohio State University), Chi‐Ping Day(National Institutes of Health), Joshi Suraj(National Cancer Institute), Yuelin Liu(National Cancer Institute)
Cited by 8
Related Papers
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
|Science|2021|876
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
|Blood|2011|638
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422